J-WAVES AND CARDIAC BIOMARKERS ARE ASSOCIATED WITH LONG-TERM CARDIOVASCULAR OUTCOMES IN HOSPITALIZED COVID-19 PATIENTS

Highlights We propose serum biomarkers as risk assessment tools for patients with COVID-19. J-waves are a common ECG finding, detected in 4–6% of the population, and are a risk factor for ventricular tachycardia and mortality in COVID-19 patients. Aim. To evaluate the prognostic potential of a combination of cardiac-specific biomarkers and ECG J-waves regarding long-term mortality and cardiovascular complications after discharge in patients with COVID-19-associated pneumonia. Methods . Serum biomarkers sST2, VCAM-1 and hs-TnI were assessed at admission in 254 patients hospitalized with COVID-19-associated pneumonia. ECGs on admission were analyzed for the presence of J waves. Clinical and laboratory characteristics of patients, as well as biomarker concentrations and the presence of J-waves on the ECG, were correlated with mortality and cardiovascular complications after discharge at 12 months [FU: 347 (310, 449) days]. Cox proportional hazards models were used to identify predictors of the risk of mortality and the composite endpoint up to one year after discharge. Results . A high level of VCAM-1 was a significant predictor of the risk of a combined endpoint (MI, stroke, pulmonary embolism, sudden death): HR = 1.049, CI 95%: 1.016–1.083; and high sST2 level was a significant predictor of the risk of both death (HR = 1.006, CI 95%: 1.004–1.007) and the composite endpoint (HR = 1.005, CI 95%: 1.003–1.006). In the generalized multivariate model, when other influencing factors were combined, the presence of a J-wave on the ECG during hospitalization was statistically insignificant (p > 0.5) for predicting sudden death up to a year after discharge. Conclusion . In hospitalized COVID-19 survivors, elevated hsTnI and sST2 levels on admission were strong predictors of CV events during long-term follow-up. On the other hand, the significance of the J-wave on the ECG in predicting long-term CV events remains borderline.

Authors

Institutions

Publication Details

Journal
Complex Issues of Cardiovascular Diseases
Published
2024-11-01
DOI
https://doi.org/10.17802/2306-1278-2024-13-3s-16-26
Primary Topic
Heart Rate Variability and Autonomic Control
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

J-WAVES AND CARDIAC BIOMARKERS ARE ASSOCIATED WITH LONG-TERM CARDIOVASCULAR OUTCOMES IN HOSPITALIZED COVID-19 PATIENTS

Irina Alexandrovna Lakman, Д. Ф. Гареева, Н. Ш. Загидуллин, Venera Timiryanova et al.
1 links
Complex Issues of Cardiovascular Diseases
Heart Rate Variability and Autonomic Control
article

J-WAVES AND CARDIAC BIOMARKERS ARE ASSOCIATED WITH LONG-TERM CARDIOVASCULAR OUTCOMES IN HOSPITALIZED COVID-19 PATIENTS

Irina Alexandrovna Lakman, Д. Ф. Гареева, Н. Ш. Загидуллин, Venera Timiryanova, L.F. Sadikova, A. A. Agapitov
article en

Abstract

Highlights We propose serum biomarkers as risk assessment tools for patients with COVID-19. J-waves are a common ECG finding, detected in 4–6% of the population, and are a risk factor for ventricular tachycardia and mortality in COVID-19 patients. Aim. To evaluate the prognostic potential of a combination of cardiac-specific biomarkers and ECG J-waves regarding long-term mortality and cardiovascular complications after discharge in patients with COVID-19-associated pneumonia. Methods . Serum biomarkers sST2, VCAM-1 and hs-TnI were assessed at admission in 254 patients hospitalized with COVID-19-associated pneumonia. ECGs on admission were analyzed for the presence of J waves. Clinical and laboratory characteristics of patients, as well as biomarker concentrations and the presence of J-waves on the ECG, were correlated with mortality and cardiovascular complications after discharge at 12 months [FU: 347 (310, 449) days]. Cox proportional hazards models were used to identify predictors of the risk of mortality and the composite endpoint up to one year after discharge. Results . A high level of VCAM-1 was a significant predictor of the risk of a combined endpoint (MI, stroke, pulmonary embolism, sudden death): HR = 1.049, CI 95%: 1.016–1.083; and high sST2 level was a significant predictor of the risk of both death (HR = 1.006, CI 95%: 1.004–1.007) and the composite endpoint (HR = 1.005, CI 95%: 1.003–1.006). In the generalized multivariate model, when other influencing factors were combined, the presence of a J-wave on the ECG during hospitalization was statistically insignificant (p > 0.5) for predicting sudden death up to a year after discharge. Conclusion . In hospitalized COVID-19 survivors, elevated hsTnI and sST2 levels on admission were strong predictors of CV events during long-term follow-up. On the other hand, the significance of the J-wave on the ECG in predicting long-term CV events remains borderline.

Complex Issues of Cardiovascular DiseasesVol. 13(3S)
University of Science and Technology (YE), Bashkir State Medical University (RU), Korea University of Science and Technology (KR)
Openalex Percentile: Top 55%
Heart Rate Variability and Autonomic Control
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.